Patients enrolled in a clinical heart transplantation program were evaluated to identify the predictors of prognosis in patients with advanced heart disease and to optimize timing of heart transplantation. Three hundred eighty-eight subjects were consecutively evaluated from 1985 through 1989. One hundred eighty-four patients (47.5%) had dilated cardiomyopathy; 164 patients (42.2%) had ischemic heart disease; 34 patients (8.8%) had valvular heart disease, and six patients (1.5%) had miscellaneous disorders. In each patient, 45 different parameters were considered. During follow-up (mean, 8.4 months) 166 patients underwent heart transplantation; 99 patients died (heart failure, 66 patients; sudden death, 26 patients; thromboembolism, two pat...
It was unclear whether increased heart rate (HR) increased long-term mortality after heart transplan...
Background: Along with advances in end-stage heart failure (HF) treatments, such as heart transplant...
Heart failure (HF) is a complex clinical syndrome that results from structural or functional cardiov...
Patients enrolled in a clinical heart transplantation program were evaluated to identify the predict...
The shortage of donor hearts emphasizes the importance of an optimal selection among candidates for ...
Heart transplantation has become the treatment of choice for patients with end-stage heart diseases....
patients with end-stage heart disease for cardiac transplantation. After complete cardiologic evalua...
Background: Cardiac transplantation (CTX) is now a viable option for patients with end-stage heart f...
Donor organ shortage demands limiting the selection of candidates for Htx to patients (pts) with the...
Chronic heart failure (CHF) patients with intermediate cardiopulmonary capacity referred for heart t...
ObjectivesTo address the present controversy regarding optimal management of status 2 heart transpla...
AbstractObjectiveEnd-stage heart failure has been associated with high mortality in the absence of t...
AimsIn heart failure (HF), prognostic risk scores focus on all-cause mortality prediction. However, ...
International audienceIntroduction: Heart transplantation (HT) remains the gold-standard treatment b...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
It was unclear whether increased heart rate (HR) increased long-term mortality after heart transplan...
Background: Along with advances in end-stage heart failure (HF) treatments, such as heart transplant...
Heart failure (HF) is a complex clinical syndrome that results from structural or functional cardiov...
Patients enrolled in a clinical heart transplantation program were evaluated to identify the predict...
The shortage of donor hearts emphasizes the importance of an optimal selection among candidates for ...
Heart transplantation has become the treatment of choice for patients with end-stage heart diseases....
patients with end-stage heart disease for cardiac transplantation. After complete cardiologic evalua...
Background: Cardiac transplantation (CTX) is now a viable option for patients with end-stage heart f...
Donor organ shortage demands limiting the selection of candidates for Htx to patients (pts) with the...
Chronic heart failure (CHF) patients with intermediate cardiopulmonary capacity referred for heart t...
ObjectivesTo address the present controversy regarding optimal management of status 2 heart transpla...
AbstractObjectiveEnd-stage heart failure has been associated with high mortality in the absence of t...
AimsIn heart failure (HF), prognostic risk scores focus on all-cause mortality prediction. However, ...
International audienceIntroduction: Heart transplantation (HT) remains the gold-standard treatment b...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
It was unclear whether increased heart rate (HR) increased long-term mortality after heart transplan...
Background: Along with advances in end-stage heart failure (HF) treatments, such as heart transplant...
Heart failure (HF) is a complex clinical syndrome that results from structural or functional cardiov...